Skip to main content

Table 1 Description of demographic and medical information of the patients

From: The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients

Variable

Median (25th and 75th percentiles)/ Number (%)

Total

(N = 80)

Survived

(N = 22)

Passed away

(N = 58)

P-Value

Age (years)

67(58.25-74)

70.50(63.50-76.25)

64(58-72.25)

0.085

Sex

Female

26 (32.5)

6 (27.3)

20 (34.5)

0.53

Male

54 (67.5)

16 (72.7)

38 (65.5)

History of chemotherapy

Yes

24 (30)

7 (31.8)

17 (29.3)

0.82

No

56 (70)

15 (68.2)

41 (70.7)

Types of Extrahepatic CCA

Distal and proximal of CBD

69 (86.3)

18 (81.8)

51 (87.9)

0.478

PeriHilar

11 (100)

4 (36.4)

7 (63.6)

0.366

AST (units/L)

84.50(54-146.50)

62(36.50-97.25)

98(63.75-156.75)

0.007

ALT (units/L)

76(46.25-129.25)

58.50(29.25–113.20)

87(50-140.50)

0.080

ALP (units/L)

1032.50(511-1426.25)

670(413.75–1193)

1098(601.25-1484.25)

0.111

Bil T (mg/dL)

12.62(5.30-24.23)

10.31(2.97–19.80)

12.97(5.68–25.18)

0.298

Bil.D (mg/dL)

7(3–13)

7(1.88–13.73)

7.30(3.30–13.30)

0.605

ALB (g/l)

2.8(2.2–3.48)

3.10(2.70–3.79)

2.50(2.10–3.40)

0.06

WBC

8300(67000 − 11000)

7000(6280–8250)

8900 (7150–11975)

0.005

NEU

5967.9(4722.9-9215.7)

5020(4481-6356.1)

6759.7(4929.6-9842.8)

0.016

Lymph

1273.2(879.3-1584.5)

1286.9(1058.3-1519.5)

1273.2(852.5-1666.5)

0.906

PLT

251,000(196500–330250)

211,000(178500–343250)

268,000(217000–318750)

0.090

PT

13.70(13.13–15.45)

13.50(12-14.55)

13.90(13.50-15.93)

0.191

INR

1.07(1-1.30)

1.01(1-1.11)

1.10(1-1.48)

0.043

ALB/Bili ratio

(0.23(0.13–0.44)

0.29(0.14–0.95)

0.20(0.12–0.38)

0.143

NEU/Lymph ratio

(4.44(3.18–9.26)

3.78(2.96–6.07)

4.97(3.29–10.03)

0.101

PLT/Lymph ratio

96.7(130.9-328.6)

174.3(129.9-278.5)

210.7(130.8-340.1)

0.055

ALBI score

-1.64(-2.42- -1.19)

-1.92(-2.67- -1.66)

-1.41(-2.19- -1.12)

0.012

ALBI Grades

Grade 1 (%)

15 (18.8)

6 (27.3)

9 (15.5)

0.01

Grade 2 (%)

34 (42.5)

13 (59.1)

21 (36.2)

Grade 3 (%)

31 (38.8)

3 (13.6)

28 (48.3)

  1. Chi square test (in qualitative variables) and Mann-Whitney U test (in quantitative variables) were used to analyze data
  2. P < 0.05 was considered significant in all tests
  3. Abbreviations: aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin-bilirubin ratio (ALBI), Alkaline phosphatase (ALP), cholangiocarcinoma (CCA), international normalized ratio (INR), lymphocyte (lymph), neutrophil (NEU), platelet (PLT), prothrombin time (PT), total bilirubin (BiliT), Direct bilirubin (Bili D), white blood cells count (WBC)